CAFARO, Giacomo
 Distribuzione geografica
Continente #
NA - Nord America 1.421
AS - Asia 1.203
EU - Europa 825
SA - Sud America 218
AF - Africa 27
Totale 3.694
Nazione #
US - Stati Uniti d'America 1.380
SG - Singapore 581
IE - Irlanda 236
BR - Brasile 191
HK - Hong Kong 188
IT - Italia 161
CN - Cina 145
RU - Federazione Russa 138
VN - Vietnam 120
KR - Corea 74
FR - Francia 51
SE - Svezia 47
DE - Germania 42
FI - Finlandia 34
GB - Regno Unito 28
CA - Canada 27
JP - Giappone 21
PL - Polonia 15
AR - Argentina 14
NL - Olanda 13
ZA - Sudafrica 13
CH - Svizzera 12
IN - India 12
BD - Bangladesh 11
MX - Messico 11
UA - Ucraina 11
ES - Italia 9
UZ - Uzbekistan 9
EC - Ecuador 8
AT - Austria 5
ID - Indonesia 5
TR - Turchia 5
HU - Ungheria 4
IL - Israele 4
IQ - Iraq 4
LT - Lituania 4
EG - Egitto 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
JO - Giordania 2
LV - Lettonia 2
MA - Marocco 2
PT - Portogallo 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
CO - Colombia 1
CU - Cuba 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GM - Gambi 1
GR - Grecia 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
Totale 3.694
Città #
Singapore 364
Dublin 233
Hong Kong 185
Chandler 176
Ashburn 134
San Mateo 89
Boardman 80
Santa Clara 74
Seoul 74
Dong Ket 70
Altamura 50
Moscow 49
Los Angeles 46
Lawrence 40
Medford 40
Princeton 40
New York 39
Wilmington 33
Perugia 32
Piscataway 24
Beijing 22
São Paulo 22
The Dalles 20
Helsinki 19
Munich 19
Falls Church 16
Hanoi 16
Tokyo 16
Ho Chi Minh City 15
Montreal 15
Andover 13
San Paolo di Civitate 13
Warsaw 13
Brooklyn 11
Saint Petersburg 11
Atlanta 10
Chicago 10
Des Moines 9
Johannesburg 9
Rio de Janeiro 9
San Francisco 9
Columbus 8
Amsterdam 7
Boston 7
Dallas 7
Hefei 7
Norwalk 7
Poplar 7
Shanghai 7
Stockholm 7
Tashkent 7
Denver 6
Mexico City 6
Orem 6
Belo Horizonte 5
Houston 5
Manchester 5
Menlo Park 5
Nuremberg 5
Redmond 5
Redwood City 5
Salvador 5
Turku 5
Chennai 4
Frankfurt Am Main 4
Lappeenranta 4
London 4
Milan 4
Quito 4
Reggio Emilia 4
Secaucus 4
Tel Aviv 4
Vicenza 4
Almaty 3
Ankara 3
Buenos Aires 3
Cadoneghe 3
Campinas 3
Charlotte 3
Council Bluffs 3
Maceió 3
Mainz 3
Montréal 3
Nanjing 3
Vienna 3
Amman 2
Arezzo 2
Belford Roxo 2
Bexley 2
Birmingham 2
Bologna 2
Brasília 2
Cairo 2
Calgary 2
Charleston 2
Chengdu 2
Cleveland 2
Clifton 2
Colombo 2
Contagem 2
Totale 2.409
Nome #
Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario? 105
A Platelet's Guide to Synovitis 89
Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: A pilot study 89
The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome 85
DETERMINATION OF TRPV1+/T LYMPHOCYTES IN INFLAMMATORY ARTHRITIS AND THEIR CORRELATION WITH ULTRASOUND FINDINGS 82
Association Between Glandular Infiltrate and Leukopenia in Sjögren Syndrome (SS): Data From the Italian Research Group on SS (GRISS) 82
Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling. 80
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 77
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy 73
Correspondence on a € Anti-inflammatory therapy for COVID-19 infection: The case for colchicine' 73
BCL2-associated athanogene 3 protein is associated with B-cell hyperactivity including lymphoma in primary sjÖgren's syndrome 72
One year in review 2019: Sjögren's syndrome 72
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 71
Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality? 71
Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections 71
Extra-articular rheumatoid arthritis 67
Effect of Sinovial High-Low® injections in trapeziometacarpal osteoarthritis 67
Salivary Gland Ultrasonography in Sjögren's Syndrome: A European Multicenter Reliability Exercise for the HarmonicSS Project 67
Platelets: a potential target for rheumatoid arthritis treatment? 66
One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren's syndrome 66
Microbiota and arthritis: cause or consequence? 65
Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome 64
Combined semiquantitative nail-enthesis complex ultrasonography and capillaroscopy in psoriasis and psoriatic arthritis 64
Drugs in induction and treatment of idiopathic inflammatory myopathies. 63
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 63
Hypertension and SARS-CoV-2 infection: is inflammation the missing link? 63
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future 62
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases 60
Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren's syndrome 58
The facts and fictions of precision medicine in autoimmune diseases: is the machine learning approach the response? 58
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment 56
Sjögren's syndrome: one year in review 2022 55
Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjögren's syndrome and rheumatoid arthritis 55
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica 55
Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy 55
Central Hemodynamics and Arterial Stiffness in Systemic Sclerosis 54
A 23-Plex Cytokine/Chemokine Analysis Identifies TNFRII, MMP-8, and sIL-1RII as Potential Biomarkers for Systemic Sclerosis 53
Ultrasound scoring systems affect the distribution of sialadenitis scores in Sjögren's syndrome: an inter-system reproducibility study 52
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis 52
Cardiovascular Involvement in Sjögren's Syndrome 52
Cardiovascular risk in systemic autoimmune diseases 50
One year in review 2018: Sjogren's syndrome. 50
One year in review 2016: Sjögren's syndrome 48
Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy 47
Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters 47
Subclinical atherosclerosis in primary Sjögren's syndrome: Does inflammation matter? 47
OP0044 Antibodies anti-saccharomyces cerevisiae in primary sjÖgren's syndrome: prevalence, clinical associations and possible cross-reactivity with disease specific autoantigens 47
Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sjögren's syndrome 47
The onset site of rheumatoid arthritis: The joints or the lung? 46
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 44
Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren's Syndrome 43
Salivary gland biopsy as a prognostic tool in Sjögren’s syndrome 43
The clinical spectrum of primary sjogren's syndrome: Beyond exocrine glands 43
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 42
Psoriatic arthritis: tissue-directed inflammation? 40
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon 40
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 39
Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review 37
Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study 37
Sjogren's syndrome: Everything you always wanted to know about genetic and epigenetic factors 36
One year in review 2021: Sjögren's syndrome 36
Comment on: "Gluten or no gluten for rheumatic diseases?‿ by Philippou E et al. 35
Cardiovascular risk in patients with Sjögren's syndrome: is it time for a new approach? 35
Impact of gender and age at onset on Sjögren's syndrome presentation and outcome: state of the art 34
Novel self-amplificatory loop between T cells and tenocytes as a driver of chronicity in tendon disease 33
Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet’s disease and autoinflammation. A viewpoint 33
Primary Sjögren's syndrome in Italy: Real-world evidence of a rare disease through administrative healthcare data 32
Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases 26
Totale 3.821
Categoria #
all - tutte 20.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021103 0 0 0 0 0 7 9 5 5 3 3 71
2021/2022314 3 61 4 9 23 12 4 72 7 12 56 51
2022/2023660 41 133 7 56 59 55 2 23 245 1 31 7
2023/2024350 21 40 8 21 5 37 80 4 29 14 46 45
2024/20251.024 29 90 19 40 120 57 40 80 249 62 159 79
2025/20261.182 161 152 157 273 299 140 0 0 0 0 0 0
Totale 3.821